# FDA Inspection 635825 - Boehringer Ingelheim Roxane Inc - December 23, 2009

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-roxane-inc/69c1b532-7049-4966-8530-8ad3f612beb6
Source feed: FDA_Inspections

> FDA Inspection 635825 for Boehringer Ingelheim Roxane Inc on December 23, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 635825
- Company Name: Boehringer Ingelheim Roxane Inc
- Inspection Date: 2009-12-23
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 701082 - 2010-12-03](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-roxane-inc/b2d485e6-c969-48cc-bd4f-62d28dcfd272)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-roxane-inc/28e717b4-8d19-4995-9599-325a24d434a3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c